US3066081A - Means for detecting galactose - Google Patents
Means for detecting galactose Download PDFInfo
- Publication number
- US3066081A US3066081A US108215A US10821561A US3066081A US 3066081 A US3066081 A US 3066081A US 108215 A US108215 A US 108215A US 10821561 A US10821561 A US 10821561A US 3066081 A US3066081 A US 3066081A
- Authority
- US
- United States
- Prior art keywords
- galactose
- implement
- solution
- color
- paper
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 229930182830 galactose Natural products 0.000 title description 37
- 108010015133 Galactose oxidase Proteins 0.000 claims description 14
- 239000000463 material Substances 0.000 claims description 14
- 102000003992 Peroxidases Human genes 0.000 claims description 10
- 108040007629 peroxidase activity proteins Proteins 0.000 claims description 10
- 239000000852 hydrogen donor Substances 0.000 claims description 8
- 229920001223 polyethylene glycol Polymers 0.000 claims description 5
- 239000002202 Polyethylene glycol Substances 0.000 claims description 4
- 239000000243 solution Substances 0.000 description 30
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 18
- 235000000346 sugar Nutrition 0.000 description 14
- 238000012360 testing method Methods 0.000 description 12
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 10
- 239000008101 lactose Substances 0.000 description 10
- 150000008163 sugars Chemical class 0.000 description 9
- 210000002700 urine Anatomy 0.000 description 9
- 102000004190 Enzymes Human genes 0.000 description 7
- 108090000790 Enzymes Proteins 0.000 description 7
- 229940088598 enzyme Drugs 0.000 description 7
- 239000004615 ingredient Substances 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- NUIURNJTPRWVAP-UHFFFAOYSA-N 3,3'-Dimethylbenzidine Chemical compound C1=C(N)C(C)=CC(C=2C=C(C)C(N)=CC=2)=C1 NUIURNJTPRWVAP-UHFFFAOYSA-N 0.000 description 6
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 6
- 230000008859 change Effects 0.000 description 6
- 235000013305 food Nutrition 0.000 description 6
- 230000035945 sensitivity Effects 0.000 description 6
- 239000003153 chemical reaction reagent Substances 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 description 5
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 4
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 description 4
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000000084 colloidal system Substances 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 150000003839 salts Chemical group 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 239000012064 sodium phosphate buffer Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 2
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 2
- 102000002322 Egg Proteins Human genes 0.000 description 2
- 108010000912 Egg Proteins Proteins 0.000 description 2
- 208000027472 Galactosemias Diseases 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 108010068370 Glutens Proteins 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 241000222640 Polyporus Species 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- 239000002250 absorbent Substances 0.000 description 2
- 230000002745 absorbent Effects 0.000 description 2
- 150000001412 amines Chemical group 0.000 description 2
- 239000003957 anion exchange resin Substances 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 239000003729 cation exchange resin Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 235000014103 egg white Nutrition 0.000 description 2
- 210000000969 egg white Anatomy 0.000 description 2
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 235000021312 gluten Nutrition 0.000 description 2
- 208000030159 metabolic disease Diseases 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- OIPPWFOQEKKFEE-UHFFFAOYSA-N orcinol Chemical compound CC1=CC(O)=CC(O)=C1 OIPPWFOQEKKFEE-UHFFFAOYSA-N 0.000 description 2
- XNGIFLGASWRNHJ-UHFFFAOYSA-N phthalic acid Chemical compound OC(=O)C1=CC=CC=C1C(O)=O XNGIFLGASWRNHJ-UHFFFAOYSA-N 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- 244000215068 Acacia senegal Species 0.000 description 1
- 235000006491 Acacia senegal Nutrition 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 240000003291 Armoracia rusticana Species 0.000 description 1
- 235000011330 Armoracia rusticana Nutrition 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 208000002177 Cataract Diseases 0.000 description 1
- 241000206575 Chondrus crispus Species 0.000 description 1
- 241000223453 Circinatus Species 0.000 description 1
- AEMOLEFTQBMNLQ-YMDCURPLSA-N D-galactopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-YMDCURPLSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 102000002464 Galactosidases Human genes 0.000 description 1
- 108010093031 Galactosidases Proteins 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 229920000569 Gum karaya Polymers 0.000 description 1
- 101001091385 Homo sapiens Kallikrein-6 Proteins 0.000 description 1
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 1
- 102100034866 Kallikrein-6 Human genes 0.000 description 1
- WZKXBGJNNCGHIC-UHFFFAOYSA-N Leucomalachite green Chemical compound C1=CC(N(C)C)=CC=C1C(C=1C=CC(=CC=1)N(C)C)C1=CC=CC=C1 WZKXBGJNNCGHIC-UHFFFAOYSA-N 0.000 description 1
- 208000036626 Mental retardation Diseases 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 108010073771 Soybean Proteins Proteins 0.000 description 1
- UQZIYBXSHAGNOE-USOSMYMVSA-N Stachyose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](CO[C@@H]2[C@@H](O)[C@@H](O)[C@@H](O)[C@H](CO)O2)O1 UQZIYBXSHAGNOE-USOSMYMVSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 239000005864 Sulphur Substances 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000370 acceptor Substances 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 239000010425 asbestos Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- DLRVVLDZNNYCBX-ZZFZYMBESA-N beta-melibiose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)O1 DLRVVLDZNNYCBX-ZZFZYMBESA-N 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 235000012839 cake mixes Nutrition 0.000 description 1
- 235000013574 canned fruits Nutrition 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 230000002939 deleterious effect Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 229940079919 digestives enzyme preparation Drugs 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- HQWKKEIVHQXCPI-UHFFFAOYSA-L disodium;phthalate Chemical compound [Na+].[Na+].[O-]C(=O)C1=CC=CC=C1C([O-])=O HQWKKEIVHQXCPI-UHFFFAOYSA-L 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000012458 free base Substances 0.000 description 1
- 229940074391 gallic acid Drugs 0.000 description 1
- 235000004515 gallic acid Nutrition 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 235000020251 goat milk Nutrition 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 235000020256 human milk Nutrition 0.000 description 1
- 210000004251 human milk Anatomy 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 235000010494 karaya gum Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- -1 pentosans Substances 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 235000015108 pies Nutrition 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 235000011962 puddings Nutrition 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 229910052895 riebeckite Inorganic materials 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 235000019710 soybean protein Nutrition 0.000 description 1
- UQZIYBXSHAGNOE-XNSRJBNMSA-N stachyose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO[C@@H]3[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O3)O)O2)O)O1 UQZIYBXSHAGNOE-XNSRJBNMSA-N 0.000 description 1
- 229910021653 sulphate ion Inorganic materials 0.000 description 1
- 230000000153 supplemental effect Effects 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/54—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving glucose or galactose
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/805—Test papers
Definitions
- This invention relates to a novel diagnostic and analytical implement and to methods for producing and utilizing it. More particularly, the invention concerns such an implement which exhibits a vivid color change when contacted with galactose per se or sugars which contain galactose in chemical combination, e.g., lactose (a betagalactoside) and rafiinose (an alpha-galactoside).
- the implement of the invention is particularly useful in diagnosing the metabolic disorder known as galactosemia and in determining whether food products can be safely ingested by persons afilicted with this ailment.
- the implement is also useful as a general analytical tool for detecting the presence of galactose, raffinose, lactose, melibiose, stachyose, etc., in materials of all kinds. Further objects of the invention will be evident from the following description wherein parts and percentages are by weight unless otherwise specified.
- the known techniques for diagnosing the ailment in question and for testing food supplies for the presence of the deleterious sugars are cumbersome and elaborate requiring scientific equipment and a highly trained operator.
- the required tests are simplicity itself and can be performed by anyone of reasonable intelligence.
- the invention comprises a test implement-An the preferred form, paper impregnated with certain reagents-which displays a vivid color change when contacted with material containing galactose.
- the implement can be utilized for diagnosis by testing specimens of urine, blood serum, etc., for the presence of galactosethe presence of this sugar indicating the existence of the ailment.
- the implement can be used in assaying foods to determine whether they are safe for persons afflicted with galactosemia, that is, whether they are free from galactose as the monosaccharide or combined in oligosaccharides such as lactose.
- galactosemia that is, whether they are free from galactose as the monosaccharide or combined in oligosaccharides such as lactose.
- the implement of the invention comprises essentially porous sheet material impregnated with (1) galactose oxidase, (2) a chromogenic hydrogen donor such as otolidine, and (3) peroxidase.
- galactose oxidase a chromogenic hydrogen donor such as otolidine
- peroxidase a chromogenic hydrogen donor
- This implement is contacted with galactose in the presence of moisture
- hydrogen peroxide is produced by the action of the en zyme galactose oxidase 011 this sugar.
- the peroxidase present in the implement converts the hydrogen peroxide to water with accompanying oxidation of the tolidine.
- the latter change is accompanied by development of a vivid blue color which provides a visual signal that the sugar galactose has contacted the implement.
- the use of the implement merely requires contact between the specimen and the implement followed by observation for color change. If the test specimen is dry, it or the implement may be moistened; if the test specimen contains water the contact of the sample and the implement is all that is necessary.
- the implement of the invention is highly sensitive and selective. centrations of galactoseas low as parts per million. Moreover, it will not give a color change when contacted with sugars other than galactose. For example, the implement will not give any color change when contacted with high concentrations of such sugars as glucose, mannose, fructose, sucrose, and the sugar-acid galac turonic acid. This selectivity is afforded by the presence of the enzyme galactose oxidase which is highly selective and oxidizes only the sugar galactose.
- the preparation of the analytical implement of the invention involves simply impregnating uncoated, absorbent paper or other porous backing material with the reagents mentioned above. These are usually applied as solutions in inert volatile solvents such as water, ethanol, methanol or the like.
- concentration of the reagents in the solutions is not critical and may be varied widely. Usually for practical purposes, a concentration of about 0.1 to 10% of each of the reagents is used.
- the backing material is impregnated with the solutions, it is dried for example by allowing it to stand in air, by subjecting it to a draft of warm air, or most preferably by holding under vacuum.
- the backing for the implement is preferably paper of an absorbent and chemically-pure grade such as filter paper
- other porous materials may be used, for example, cloth, porous ceramics, asbestos fiber, etc.
- the reagent which is employed to develop a color on oxidation is preferably orthotolidine.
- any other organic compound which is essentially colorless and which forms a colored oxidation product in the presence of peroxide and peroxidase may be generically referred to as chromogenic hydrogen donors or chromogenic oxygen acceptors. Illustrative examples of such compounds are listed below.
- color-developing reagent is an amine
- it is generally employed in its free base from but may also be employed in salt form, for example, as a salt with hydrochloric acid, sulphur acid, acetic acid, citric acid, phthalic acid, or other acid which does not exert an oxidizing effect on the amine.
- the imple- Thus it will detect minute conment may be standardized to produce a particular level of color when contacted with a galactose solution of specific concentration.
- concentration of active ingredients in the implement may be regulated to provide a product which will give the same color when exposed to the same concentration of galactose in any test specimen.
- the materials absorbed on the porous backing include a buffer having a pH of approximate neutrality, that is, a pH about from 6.0 to 8.
- a buffer having a pH of approximate neutrality that is, a pH about from 6.0 to 8.
- any of the usual salts or mixtures thereof known to provide such p-H such as sodium phosphate buffers, sodium phthalate buffers, and the like.
- the implement of the invention may take various forms, depending on the type of use intended for it. For example, if it is intended that the implement respond only to glactose itself but not to sugars containing galactose in chemical combination, then the essential components of the implement would be galactose oxidase, the chromogenic hydrogen donor, and peroxidase. If on the other hand it is desired that the implement respond to sugars containing galactose in chemical combination as well as galactose itself, then various auxiliary enzymes may be incorporated therein. For example, one may incorporate the enzyme B-galactosidase together with the primary ingredients (galactose oxidase, chromogenic hydrogen donor and peroxidase).
- This modification of the invention is responsive to lactose and other fl-galactosides as well as galactose.
- the ,B-galactosidase will split the lactose into galactose and glucose.
- the galactose so formed will yield the color signal as described.
- Another variation is to include the enzyme a-galactosidase with the primary ingredients.
- Such modification of the invention will respond to raffinose and other a-galactosides as well as galactose.
- the a-galactosidase is elfective in splitting raffinose into galactose and sucrose, the former providing the visual signal as described.
- a further variation is to incorporate both czand ,B-galactosidase with the primary ingredients o afford an implement which is responsive to galactose, raffinose, lactose and other ozor fi-galactosides.
- auxiliary enzymes include a-galactosidase and/ or fl-galactosidase as co-biosynthesized products.
- Such enzyme preparations may be produced as known in the art by culture of various microorganisms including selected strains of Polyporus cil'cinatus. By applying conventional enzyme purification techniques to the bacterial preparations, one may obtain pure galactose oxidase or products containing this enzyme plus the galactosidases.
- a hydrophilic colloid is added with the other ingredients on the porous backing material.
- the colloidal material acts to stabilize and protect the active materials so that the implement can be stored for long periods without loss of activity, uniformity, or sensitivity.
- Typical examples of colloids which can be used for the purpose are egg white, gelatin, bovine serum albumin, polyethylene glycols (for example, those having a molecular weight from 500 to 50,000), soluble starch, sodium carboxymethyl cellulose, methyl cellulose, polyvinylpyrrolidone, agar, gum tragacanth, gum acacia, gum karaya, carragheen, algin, pectin, dextran, sodium carboxymethyl starch, pentosans, sodium gluten sulphate, sodium gluten phosphate, dried glucosefree egg white, water-soluble soybean protein, and the like.
- the amount of hydrophilic colloid is not critical; generally it is used in the proportion of about 25 to 250%, based on the weight of galacto
- galactose oxidase prepared from Polyporus circinatus
- horseradish peroxidase horseradish peroxidase
- Example 11 A sample of human urine was divided into portions and to each was added a measured amount of galactose. These solutions were then applied to the paper strips prepared in Example I by placing a drop of each solution on the strip. It was found that visible blue color was formed with all the solutions including the one of lowest concentration-0.5 mg. galactose per ml.
- Example Ill Chemically-pure filter paper was dipped in a 1.5% solution of o-tolidine in methanol, then dried in air.
- the paper was dried in a stream of warm air.
- the resulting product olf-white in color, was tested for sensitivity in detecting galactose in human urine. Measured amounts of galactose were added to several portions of urine and each portion was then de-ionized by contact with a mixture of an anion exchange resin and a cation exchange resin. (Such treatment of the urine has been found to increase the sensitivity of the response of the test paper to galactose.) Following this treatment, the test paper was contacted with the urine samples. A visible blue color was formed with solutions containing as little as 0.1 mg. galactose per ml.
- Example IV Chemically-pure filter paper was dipped in a 1% solution of o-tolidine in methanol, then dried in air.
- a solution was prepared containing the following ingredients.
- Example V Chemically-pure filter paper was dipped in a 1% solution of o-tolidine in methanol then dried in air.
- a solution was prepared containing the following materials.
- the o-tolidine-impregnated paper was immersed in this solution, removed, drained and freeze-dried under vacuum.
- the resulting product white in color, was tested for sensitivity in detecting galactose in aqueous solution. A visible blue color was developed with solutions containing as little as 0.075 mg. galactose per ml.
- Example VI Chemically-pure filter paper was dipped in a 1% solution of o-tolidine in methanol, then dried in air.
- a solution was prepared containing the following materials.
- a process for preparing an analytical implement which comprises impregnating porous sheet material with a solution containing 1) galactose oxidase, (2) a chromogenic hydrogen donor, (3) peroxidase, and (4) a polyethylene glycol having a molecular weight about from 500 to 50,000.
- a method for testing urine for the presence of galactose which comprises de-ionizing the urine by treating it with an anion exchange resin and a cation exchange resin and contacting the de-ionized urine with an analytical implement comprising porous sheet material impregnated with (1) galactose oxidase, (2) a chromogenic hydrogen donor, and (3) peroxidase.
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Emergency Medicine (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Description
a one United States Patent Ofitice 3,0fi6fi3l Patented Nov. 27, 1962 3,066,081 MEANS FOR DETECTING GALACTOSE Edward S. Rorem and James C. Lewis, Berkeley, Calif.,
assignors to the United States of America as represented by the Secretary of Agriculture No Drawing. Filed May 5, 1961, Ser. No. 108,215
3 Claims. (Cl. 195-1035) (Granted under Title 35, US. Code (1952), see. 266) A non-exclusive, irrevocable, royalty-free license in the invention herein described, throughout the world for all purposes of the United States Government, with the power to grant sublicenses for such purposes, is hereby granted to the Government of the United States of America.
This invention relates to a novel diagnostic and analytical implement and to methods for producing and utilizing it. More particularly, the invention concerns such an implement which exhibits a vivid color change when contacted with galactose per se or sugars which contain galactose in chemical combination, e.g., lactose (a betagalactoside) and rafiinose (an alpha-galactoside). The implement of the invention is particularly useful in diagnosing the metabolic disorder known as galactosemia and in determining whether food products can be safely ingested by persons afilicted with this ailment. The implement is also useful as a general analytical tool for detecting the presence of galactose, raffinose, lactose, melibiose, stachyose, etc., in materials of all kinds. Further objects of the invention will be evident from the following description wherein parts and percentages are by weight unless otherwise specified.
It is known that certain children are born with an inability to utilize the sugar galactose. This metabolic disorder causes serious troubleincluding mental retardation, development of cataracts, etc-if the children are fed foods containing galactose, as such, or combined with other sugars as in lactose and rafinose. Such sugars commonly occur in natural products as human milk, cows milk, goat milk, etc., and in many manufactured items, for example, ice cream, canned puddings, canned fruits and vegetables, pie and cake mixes, etc. The proper feeding of children afllicted with the disorder requires constant vigilance to the end that their food supply is completely free from the sugars in question.
The known techniques for diagnosing the ailment in question and for testing food supplies for the presence of the deleterious sugars are cumbersome and elaborate requiring scientific equipment and a highly trained operator. In accordance with the invention the required tests are simplicity itself and can be performed by anyone of reasonable intelligence. In essence, the invention comprises a test implement-An the preferred form, paper impregnated with certain reagents-which displays a vivid color change when contacted with material containing galactose. The implement can be utilized for diagnosis by testing specimens of urine, blood serum, etc., for the presence of galactosethe presence of this sugar indicating the existence of the ailment. Also, the implement can be used in assaying foods to determine whether they are safe for persons afflicted with galactosemia, that is, whether they are free from galactose as the monosaccharide or combined in oligosaccharides such as lactose. These tests are so simple, requiring merely contact of the implement with the specimen to be tested and observation of the color thereof, that no scien tific skill whatever is needed. Thus, for example, the mother of the afllicted child can use the implement routinely in testing all foods offered to her child without requiring any training in chemistry or related sciences.
The implement of the invention comprises essentially porous sheet material impregnated with (1) galactose oxidase, (2) a chromogenic hydrogen donor such as otolidine, and (3) peroxidase. When this implement is contacted with galactose in the presence of moisture, hydrogen peroxide is produced by the action of the en zyme galactose oxidase 011 this sugar. The peroxidase present in the implement converts the hydrogen peroxide to water with accompanying oxidation of the tolidine. The latter change is accompanied by development of a vivid blue color which provides a visual signal that the sugar galactose has contacted the implement. It is thus evident that the use of the implement merely requires contact between the specimen and the implement followed by observation for color change. If the test specimen is dry, it or the implement may be moistened; if the test specimen contains water the contact of the sample and the implement is all that is necessary. It is to be emphasized that the implement of the invention is highly sensitive and selective. centrations of galactoseas low as parts per million. Moreover, it will not give a color change when contacted with sugars other than galactose. For example, the implement will not give any color change when contacted with high concentrations of such sugars as glucose, mannose, fructose, sucrose, and the sugar-acid galac turonic acid. This selectivity is afforded by the presence of the enzyme galactose oxidase which is highly selective and oxidizes only the sugar galactose.
The preparation of the analytical implement of the invention involves simply impregnating uncoated, absorbent paper or other porous backing material with the reagents mentioned above. These are usually applied as solutions in inert volatile solvents such as water, ethanol, methanol or the like. The concentration of the reagents in the solutions is not critical and may be varied widely. Usually for practical purposes, a concentration of about 0.1 to 10% of each of the reagents is used. After the backing material is impregnated with the solutions, it is dried for example by allowing it to stand in air, by subjecting it to a draft of warm air, or most preferably by holding under vacuum.
Although the backing for the implement is preferably paper of an absorbent and chemically-pure grade such as filter paper, other porous materials may be used, for example, cloth, porous ceramics, asbestos fiber, etc.
The reagent which is employed to develop a color on oxidation is preferably orthotolidine. However, one can use any other organic compound which is essentially colorless and which forms a colored oxidation product in the presence of peroxide and peroxidase. Such compounds may be generically referred to as chromogenic hydrogen donors or chromogenic oxygen acceptors. Illustrative examples of such compounds are listed below.
Benzidine, o-methylbenzidine, m-tolidine, 3,3'-diethyl- 4,4-diaminodiphenyl, o-dianisidine, o-phenylenediamine, m-phenylenediamine, p-phenylenediamine, 2,3-toluylene diamine, 2,4-toluylenediamine, 2,5-toluylenediamine, 2,6- toluylenediamine, 3,4-toluylenediamine, 3,5-toluylenediamine, 1,2,3-triaminobenzene, 1,2,4-triaminobenzene, 2,4, 6-triaininobenzene, 4,4-diaminodiphenyl methane, pyrogallic acid, guaiacol, catechol, hyd-roquinone, toluhydroquinone, pyrogallol, phloroglucinol, thymol, resorcinol,
orcinol, gallic acid, pyrocatechic acid, leucomalachite green, etc.
Where the color-developing reagent is an amine, it is generally employed in its free base from but may also be employed in salt form, for example, as a salt with hydrochloric acid, sulphur acid, acetic acid, citric acid, phthalic acid, or other acid which does not exert an oxidizing effect on the amine.
It is obvious that for calibration purposes, the imple- Thus it will detect minute conment may be standardized to produce a particular level of color when contacted with a galactose solution of specific concentration. Thus the concentration of active ingredients in the implement may be regulated to provide a product which will give the same color when exposed to the same concentration of galactose in any test specimen.
In most cases it is preferred that the materials absorbed on the porous backing include a buffer having a pH of approximate neutrality, that is, a pH about from 6.0 to 8. For such purpose one may employ any of the usual salts or mixtures thereof known to provide such p-H, such as sodium phosphate buffers, sodium phthalate buffers, and the like.
The implement of the invention may take various forms, depending on the type of use intended for it. For example, if it is intended that the implement respond only to glactose itself but not to sugars containing galactose in chemical combination, then the essential components of the implement would be galactose oxidase, the chromogenic hydrogen donor, and peroxidase. If on the other hand it is desired that the implement respond to sugars containing galactose in chemical combination as well as galactose itself, then various auxiliary enzymes may be incorporated therein. For example, one may incorporate the enzyme B-galactosidase together with the primary ingredients (galactose oxidase, chromogenic hydrogen donor and peroxidase). This modification of the invention is responsive to lactose and other fl-galactosides as well as galactose. Thus, if the implement is contacted with lactose the ,B-galactosidase will split the lactose into galactose and glucose. The galactose so formed will yield the color signal as described. Another variation is to include the enzyme a-galactosidase with the primary ingredients. Such modification of the invention will respond to raffinose and other a-galactosides as well as galactose. Thus, the a-galactosidase is elfective in splitting raffinose into galactose and sucrose, the former providing the visual signal as described. A further variation is to incorporate both czand ,B-galactosidase with the primary ingredients o afford an implement which is responsive to galactose, raffinose, lactose and other ozor fi-galactosides. Although such supplemental effects are generally achieved through deliberate incorporation of the auxiliary enzymes into the implement, equivalent results may be achieved by employing preparations of galactose oxidase which contain a-galactosidase and/ or fl-galactosidase as co-biosynthesized products. Such enzyme preparations may be produced as known in the art by culture of various microorganisms including selected strains of Polyporus cil'cinatus. By applying conventional enzyme purification techniques to the bacterial preparations, one may obtain pure galactose oxidase or products containing this enzyme plus the galactosidases.
In a preferred embodiment of the invention a hydrophilic colloid is added with the other ingredients on the porous backing material. The colloidal material acts to stabilize and protect the active materials so that the implement can be stored for long periods without loss of activity, uniformity, or sensitivity. Typical examples of colloids which can be used for the purpose are egg white, gelatin, bovine serum albumin, polyethylene glycols (for example, those having a molecular weight from 500 to 50,000), soluble starch, sodium carboxymethyl cellulose, methyl cellulose, polyvinylpyrrolidone, agar, gum tragacanth, gum acacia, gum karaya, carragheen, algin, pectin, dextran, sodium carboxymethyl starch, pentosans, sodium gluten sulphate, sodium gluten phosphate, dried glucosefree egg white, water-soluble soybean protein, and the like. The amount of hydrophilic colloid is not critical; generally it is used in the proportion of about 25 to 250%, based on the weight of galactose oxidase.
The invention is further demonstrated by the following illustrative examples.
4 Example I Chemically-pure filter paper was dipped in a 1% solution of o-tolidine in methanol, then dried in air. The paper was then dipped in 0.5 M (pH 7.3) sodium phosphate buffer solution, then dried in air.
Two and one-half parts of galactose oxidase (prepared from Polyporus circinatus) and 1 part of horseradish peroxidase were dissolved in 200 parts water. The pap r was immersed in this solution then removed and dried in a vacuum desiccator.
The paper so prepared, white in color, was cut into strips for use.
Example 11 A sample of human urine was divided into portions and to each was added a measured amount of galactose. These solutions were then applied to the paper strips prepared in Example I by placing a drop of each solution on the strip. It was found that visible blue color was formed with all the solutions including the one of lowest concentration-0.5 mg. galactose per ml.
The procedure as described above was repeated but applying the implement to solutions of galactose in water. In this case it was found that a visible blue color was formed with all the solutions including the one of lowest concentration--0.1 mg. galactose per ml. in this case.
Example Ill Chemically-pure filter paper was dipped in a 1.5% solution of o-tolidine in methanol, then dried in air. The
paper was then dipped in a solution containing the following ingredients:
Following dipping in the above solution, the paper was dried in a stream of warm air.
The resulting product, olf-white in color, was tested for sensitivity in detecting galactose in human urine. Measured amounts of galactose were added to several portions of urine and each portion was then de-ionized by contact with a mixture of an anion exchange resin and a cation exchange resin. (Such treatment of the urine has been found to increase the sensitivity of the response of the test paper to galactose.) Following this treatment, the test paper was contacted with the urine samples. A visible blue color was formed with solutions containing as little as 0.1 mg. galactose per ml.
Example IV Chemically-pure filter paper was dipped in a 1% solution of o-tolidine in methanol, then dried in air.
A solution was prepared containing the following ingredients.
The resulting product, white in color, was tested for sensitivity in detecting galactose in aqueous solution. A visible blue color developed with solutions containing as little as 0.075 mg. galactose per ml.
Example V Chemically-pure filter paper was dipped in a 1% solution of o-tolidine in methanol then dried in air.
A solution was prepared containing the following materials.
The o-tolidine-impregnated paper was immersed in this solution, removed, drained and freeze-dried under vacuum.
The resulting product, white in color, was tested for sensitivity in detecting galactose in aqueous solution. A visible blue color was developed with solutions containing as little as 0.075 mg. galactose per ml.
Example VI Chemically-pure filter paper was dipped in a 1% solution of o-tolidine in methanol, then dried in air.
A solution was prepared containing the following materials.
Ingredient: Proportion, parts Galactose oxidase 15 Solution containing S-galactosidase,
obtained by grinding cells of an E. coli mutant in water 500 Peroxidase (horseradish) 2.5 Water 300 1 M sodium phosphate buffer (pH 7.2) 200 Polyethylene glycol having average molecular weight of 20,000 30 The o-tolidine-impregnated paper was immersed in this solution, removed, drained and freeze-dried under vacuum. The resulting product, white in color, was tested for 6 sensitivity in detecting lactose in aqueous solution. A visible blue color developed with solutions containing as little as 1 mg. lactose per ml. of solution.
Having thus described the invention, what is claimed is:
1. An analytical implement comprising porous sheet material impregnated with (=1) galactose oxidase, (2) a chromogenic hydrogen donor, (3) peroxidase, and (4) a polyethylene glycol having a molecular weight about from 500 to 50,000.
2. A process for preparing an analytical implement which comprises impregnating porous sheet material with a solution containing 1) galactose oxidase, (2) a chromogenic hydrogen donor, (3) peroxidase, and (4) a polyethylene glycol having a molecular weight about from 500 to 50,000.
3. A method for testing urine for the presence of galactose which comprises de-ionizing the urine by treating it with an anion exchange resin and a cation exchange resin and contacting the de-ionized urine with an analytical implement comprising porous sheet material impregnated with (1) galactose oxidase, (2) a chromogenic hydrogen donor, and (3) peroxidase.
References Cited in the file of this patent UNITED STATES PATENTS 2,893,844 Cook July 7, 1959 3,001,915 Fonner Sept. 26, 1961 3,005,714 Cooper Oct. 24, 1961 3,016,292 Bauer et a1. Ian. 9, 1962 OTHER REFERENCES Sumner et al.: Chemistry and Methods of Enzymes, 1953, Academic Press, New York, pages -111.
Cooper et al. J. Biol. Chem, March 1959, vol. 234,
5 No. 3, pages 445-448.
Claims (1)
1. AN ANALYTICAL IMPLEMENT COMPRISING POROUS SHEET MATERIAL IMPREGNATED WITH (1) GALACTOSE OXIDASE, (2) A CHROMOGENIC HYDROGEN DONOR, (3) PEROXIDASE, AND (4) A POLYETHYLENE GLYCOL HAVING A MOLECULAR WEIGHT ABOUT FROM 500 TO 50,000.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US108215A US3066081A (en) | 1961-05-05 | 1961-05-05 | Means for detecting galactose |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US108215A US3066081A (en) | 1961-05-05 | 1961-05-05 | Means for detecting galactose |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| US3066081A true US3066081A (en) | 1962-11-27 |
Family
ID=22320922
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US108215A Expired - Lifetime US3066081A (en) | 1961-05-05 | 1961-05-05 | Means for detecting galactose |
Country Status (1)
| Country | Link |
|---|---|
| US (1) | US3066081A (en) |
Cited By (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3157470A (en) * | 1962-03-19 | 1964-11-17 | Charles M Andrews | Test for cavitoma |
| US3278394A (en) * | 1963-07-22 | 1966-10-11 | Miles Lab | Method and composition for diagnosing glucose |
| US3298789A (en) * | 1964-12-14 | 1967-01-17 | Miles Lab | Test article for the detection of glucose |
| US3362886A (en) * | 1965-04-09 | 1968-01-09 | Miles Lab | Composition and method for the detection of galactose |
| US3367842A (en) * | 1965-02-17 | 1968-02-06 | Miles Lab | Test composition and device for the detection of galactose in fluids |
| US3371019A (en) * | 1965-01-08 | 1968-02-27 | Searle & Co | Diagnostic indicator |
| US3395082A (en) * | 1964-07-20 | 1968-07-30 | Miles Lab | Test composition device and method for detecting urea in aqueous fluids |
| US3532603A (en) * | 1966-08-15 | 1970-10-06 | Castrol Ltd | Determination of bacteria |
| USRE28575E (en) * | 1971-03-01 | 1975-10-21 | Indicator for detecting hydrogen peroxide and peroxidative compounds containing alpha naphthoflavone | |
| US3926732A (en) * | 1973-02-16 | 1975-12-16 | Alfa Laval Ab | Method for assaying catalase in milk and other liquids |
| US4298688A (en) * | 1978-07-25 | 1981-11-03 | Veb Arzneimittelwerk Dresden | Test device for the detection and determination of glucose |
| US4956300A (en) * | 1982-01-05 | 1990-09-11 | Helena Laboratories Corporation | Aid for determining the presence of occult blood, method of making the aid, and method of using the aid |
| US5081040A (en) * | 1987-06-29 | 1992-01-14 | Helena Laboratories Corporation | Composition and kit for testing for occult blood in human and animal excretions, fluids, or tissue matrixes |
| US5196167A (en) * | 1989-04-04 | 1993-03-23 | Helena Laboratories Corporation | Fecal occult blood test product with positive and negative controls |
| US5217874A (en) * | 1989-04-04 | 1993-06-08 | Helena Laboratories Corporation | Fecal occult blood test product with positive and negative controls |
| US5273888A (en) * | 1984-01-16 | 1993-12-28 | Helena Laboratories Corporation | Chemical test kit and method for determining the presence of blood in a specimen and for verifying the effectiveness of the chemicals |
| US5702913A (en) * | 1983-12-21 | 1997-12-30 | Helena Laboratories Corporation | Chromgen-reagent test system |
| CN102081090A (en) * | 2009-11-30 | 2011-06-01 | 苏州艾杰生物科技有限公司 | Measurement method and diagnosis/measurement kit of galactose |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2893844A (en) * | 1957-01-08 | 1959-07-07 | Miles Lab | Composition of matter |
| US3001915A (en) * | 1957-12-16 | 1961-09-26 | Miles Lab | Diagnostic composition |
| US3005714A (en) * | 1959-08-26 | 1961-10-24 | Univ Northwestern | Galactose oxidase |
| US3016292A (en) * | 1959-05-15 | 1962-01-09 | Miles Lab | Diagnostic composition |
-
1961
- 1961-05-05 US US108215A patent/US3066081A/en not_active Expired - Lifetime
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2893844A (en) * | 1957-01-08 | 1959-07-07 | Miles Lab | Composition of matter |
| US3001915A (en) * | 1957-12-16 | 1961-09-26 | Miles Lab | Diagnostic composition |
| US3016292A (en) * | 1959-05-15 | 1962-01-09 | Miles Lab | Diagnostic composition |
| US3005714A (en) * | 1959-08-26 | 1961-10-24 | Univ Northwestern | Galactose oxidase |
Cited By (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3157470A (en) * | 1962-03-19 | 1964-11-17 | Charles M Andrews | Test for cavitoma |
| US3278394A (en) * | 1963-07-22 | 1966-10-11 | Miles Lab | Method and composition for diagnosing glucose |
| US3395082A (en) * | 1964-07-20 | 1968-07-30 | Miles Lab | Test composition device and method for detecting urea in aqueous fluids |
| US3298789A (en) * | 1964-12-14 | 1967-01-17 | Miles Lab | Test article for the detection of glucose |
| US3371019A (en) * | 1965-01-08 | 1968-02-27 | Searle & Co | Diagnostic indicator |
| US3367842A (en) * | 1965-02-17 | 1968-02-06 | Miles Lab | Test composition and device for the detection of galactose in fluids |
| US3362886A (en) * | 1965-04-09 | 1968-01-09 | Miles Lab | Composition and method for the detection of galactose |
| US3532603A (en) * | 1966-08-15 | 1970-10-06 | Castrol Ltd | Determination of bacteria |
| USRE28575E (en) * | 1971-03-01 | 1975-10-21 | Indicator for detecting hydrogen peroxide and peroxidative compounds containing alpha naphthoflavone | |
| US3926732A (en) * | 1973-02-16 | 1975-12-16 | Alfa Laval Ab | Method for assaying catalase in milk and other liquids |
| US4298688A (en) * | 1978-07-25 | 1981-11-03 | Veb Arzneimittelwerk Dresden | Test device for the detection and determination of glucose |
| US4956300A (en) * | 1982-01-05 | 1990-09-11 | Helena Laboratories Corporation | Aid for determining the presence of occult blood, method of making the aid, and method of using the aid |
| US5702913A (en) * | 1983-12-21 | 1997-12-30 | Helena Laboratories Corporation | Chromgen-reagent test system |
| US5273888A (en) * | 1984-01-16 | 1993-12-28 | Helena Laboratories Corporation | Chemical test kit and method for determining the presence of blood in a specimen and for verifying the effectiveness of the chemicals |
| US5081040A (en) * | 1987-06-29 | 1992-01-14 | Helena Laboratories Corporation | Composition and kit for testing for occult blood in human and animal excretions, fluids, or tissue matrixes |
| US5196167A (en) * | 1989-04-04 | 1993-03-23 | Helena Laboratories Corporation | Fecal occult blood test product with positive and negative controls |
| US5217874A (en) * | 1989-04-04 | 1993-06-08 | Helena Laboratories Corporation | Fecal occult blood test product with positive and negative controls |
| CN102081090A (en) * | 2009-11-30 | 2011-06-01 | 苏州艾杰生物科技有限公司 | Measurement method and diagnosis/measurement kit of galactose |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US3066081A (en) | Means for detecting galactose | |
| US3598704A (en) | Diagnostic device for various sugars | |
| US3099605A (en) | Diagnostic composition | |
| Campanella et al. | Determination of antioxidant properties of aromatic herbs, olives and fresh fruit using an enzymatic sensor | |
| US5156947A (en) | Process for reduction of the matrix effect in a fructosamine determination assay | |
| CA1137397A (en) | Precursor indicator compositions | |
| US4211845A (en) | Glucose indicator and method | |
| US4303753A (en) | Method and device for the semiquantitative determination of glucose in aqueous fluids | |
| Abou Akkada et al. | The biochemistry of rumen protozoa. 4. Decomposition of pectic substances | |
| US3290228A (en) | Test composition and device for detecting glucose | |
| US4251223A (en) | Sensitizers for peroxidative activity tests | |
| SE8001063L (en) | PROCEDURE FOR DETERMINING GLUCOSE IN A TEST OF A BODY LIQUID AND TEST ORGAN AND TESTING DEVICE FOR IMPLEMENTATION OF THE PROCEDURE | |
| GB960167A (en) | Improvements in or relating to diagnostic compositions | |
| US3926732A (en) | Method for assaying catalase in milk and other liquids | |
| US3104209A (en) | Composition for determination of glucose | |
| US4251222A (en) | Sensitizers for peroxidative activity tests | |
| US3005714A (en) | Galactose oxidase | |
| CS226718B2 (en) | Composition for removing ascorbic acid from aqueous liquid substances | |
| Farrell | Studies on the Respiratory Mechanism of the Streptococci | |
| US3413197A (en) | Controlled sensitivity galactose test composition and process | |
| US3362886A (en) | Composition and method for the detection of galactose | |
| US3233974A (en) | Diagnostic compositions | |
| DK167197B1 (en) | METHOD AND PROCEDURE FOR BILIRUBINE RESISTANT DETERMINATION OF URIC ACID | |
| DE2737288C2 (en) | A method for determining the free and / or bound glycerol present in the form of triglycerides in aqueous liquids, as well as a determination reagent for carrying out the method and a determination reagent for the determination of adenosine triphosphate | |
| US3367842A (en) | Test composition and device for the detection of galactose in fluids |